Trading Report: Today, 260 Shares of Praxair Inc. (PX) are sold by Nichols & Pratt Advisers LLP MA

Today, 260 Shares of Praxair Inc. (PX) are sold by Nichols & Pratt Advisers LLP MA

Nichols & Pratt Advisers LLP MA decreased its position in shares of Praxair Inc. (NYSE:PX) by 0.2% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 159,390 shares of the company’s stock after selling 260 shares during the period. Praxair makes up approximately 1.8% of Nichols & Pratt Advisers LLP MA’s portfolio, making the stock its 17th largest position. Nichols & Pratt Advisers LLP MA owned approximately 0.06% of Praxair worth $19,259,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Guyasuta Investment Advisors Inc. boosted its stake in shares of Praxair by 2.2% in the third quarter. Guyasuta Investment Advisors Inc. now owns 130,524 shares of the company’s stock worth $15,771,000 after buying an additional 2,797 shares during the period. Smithfield Trust Co. raised its position in shares of Praxair by 4.7% in the third quarter. Smithfield Trust Co. now owns 7,832 shares of the company’s stock worth $946,000 after buying an additional 350 shares in the last quarter. CIBC World Markets Inc. raised its position in shares of Praxair by 43.4% in the third quarter. CIBC World Markets Inc. now owns 13,486 shares of the company’s stock worth $1,630,000 after buying an additional 4,080 shares in the last quarter. Commerce Bank raised its position in shares of Praxair by 4.8% in the third quarter. Commerce Bank now owns 33,317 shares of the company’s stock worth $4,025,000 after buying an additional 1,523 shares in the last quarter. Finally, Toronto Dominion Bank raised its position in shares of Praxair by 151.1% in the third quarter. Toronto Dominion Bank now owns 11,440 shares of the company’s stock worth $1,383,000 after buying an additional 6,884 shares in the last quarter. 83.63% of the stock is currently owned by hedge funds and other institutional investors.

Praxair Inc. (NYSE:PX) traded up 0.31% during midday trading on Friday, reaching $119.08. The company’s stock had a trading volume of 351,979 shares. Praxair Inc. has a 12-month low of $95.60 and a 12-month high of $125.00. The firm has a market cap of $33.98 billion, a price-to-earnings ratio of 22.59 and a beta of 0.95. The company’s 50-day moving average is $117.73 and its 200 day moving average is $116.43.

Praxair (NYSE:PX) last announced its quarterly earnings data on Thursday, October 27th. The company reported $1.41 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.40 by $0.01. Praxair had a return on equity of 29.92% and a net margin of 14.46%. The business had revenue of $2.70 billion for the quarter, compared to the consensus estimate of $2.70 billion. During the same period in the previous year, the business earned $1.46 earnings per share. The business’s revenue was up 1.1% on a year-over-year basis. Equities analysts forecast that Praxair Inc. will post $5.47 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Wednesday, December 7th will be given a $0.75 dividend. The ex-dividend date of this dividend is Monday, December 5th. This represents a $3.00 annualized dividend and a dividend yield of 2.53%. Praxair’s payout ratio is 56.82%.

PX has been the topic of a number of research analyst reports. TheStreet upgraded Praxair from a “hold” rating to a “buy” rating in a research note on Monday, August 29th. Jefferies Group restated a “buy” rating and issued a $140.00 target price on shares of Praxair in a research note on Tuesday, August 16th. Barclays PLC upped their target price on Praxair from $120.00 to $125.00 and gave the stock an “equal weight” rating in a research note on Friday, July 29th. Morgan Stanley initiated coverage on Praxair in a research note on Tuesday, September 13th. They issued an “equal weight” rating and a $125.00 target price on the stock. Finally, Argus restated a “hold” rating on shares of Praxair in a research note on Tuesday, August 16th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $118.57.

In related news, insider Anne K. Roby sold 17,103 shares of the business’s stock in a transaction dated Monday, October 31st. The stock was sold at an average price of $117.40, for a total value of $2,007,892.20. Following the sale, the insider now directly owns 19,337 shares in the company, valued at $2,270,163.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Raymond W. Leboeuf sold 6,550 shares of the business’s stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $117.26, for a total value of $768,053.00. Following the completion of the sale, the director now owns 16,697 shares in the company, valued at $1,957,890.22. The disclosure for this sale can be found here. 0.22% of the stock is owned by insiders.

Praxair Company Profile

Related posts

Leave a Comment